Seeing Is Believing
JNCE is currently covered by 6 analysts with an average price target of $4.65. This is a potential upside of $4.65 (0%) from yesterday's end of day stock price of $0.
Jounce Therapeutics's activity chart (see below) currently has 26 price targets and 31 ratings on display. The stock rating distribution of JNCE is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 15.63% with an average time for these price targets to be met of 262 days.
Highest price target for JNCE is $8, Lowest price target is $1, average price target is $4.65.
Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 28-Mar-2023.
Currently out of the existing stock ratings of JNCE, 8 are a BUY (66.67%), 4 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2
$0.12 (6.38%)
7
1 years ago
0/4 (0%)
$0.16 (8.70%)
Hold
3
1 years 1 months 5 days ago
2/8 (25%)
$1.82 (154.24%)
622
Buy
5
$3.12 (165.96%)
9
1 years 2 months 25 days ago
0/4 (0%)
$3.91 (358.72%)
Buy
11
$9.12 (485.11%)
15
1 years 7 months 23 days ago
0/2 (0%)
$6.84 (164.42%)
Buy
15
$13.12 (697.87%)
15
1 years 10 months 16 days ago
0/4 (0%)
$10.75 (252.94%)
What is JNCE (Jounce Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the current lower performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?
Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?
Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?